The present invention relates generally to surgical lasers and more specifically to a laser beam control and delivery system that accurately and efficiently directs a laser beam into an optical fiber. The laser beam control and delivery system also provides additional functions, including a connection for a fiber tip temperature control system and a tissue temperature sensing system. The present invention also relates to a surgical laser system that has a high efficiency thermoelectric cooling system.

Systems for enabling delivery of very high peak power laser pulses through optical fibers for use in ablation procedures preferably in contact mode. Such lasers advantageously emit at 355 nm wavelength. Other systems enable selective removal of undesired tissue within a blood vessel, while minimizing the risk of damaging the blood vessel itself, based on the use of the ablative properties of short laser pulses of 320 to 400 nm laser wavelength, with selected parameters of the mechanical walls of the tubes constituting the catheter, of the laser fluence and of the force that is applied by the catheter on the tissues. Additionally, a novel method of calibrating such catheters is disclosed, which also enables real time monitoring of the ablation process. Additionally, novel methods of protecting the fibers exit facets are disclosed.

A tubular optically-transparent device structured as a terminating cap for an optical fiber is configured to deliver laser radiation from the optical fiber substantially radially (generallytransversely to the axis of the cap) while at the same time spatially-redistributing the radiant intensity at a point of interaction of laser radiation with a wall of the cap to reduce material damage of the material of the cap thereby reducing tissue adhesion during surgery performed with the use of the device including such optical fiber and cap. A method for operating the same.

A medical device may include an elongated body having a distal elongated body portion and a central longitudinal axis. The medical device may include a balloon positioned along the distal elongated body portion. The balloon may be configured to receive a fluid to inflate the balloon such that an exterior balloon surface contacts a calcified lesion within a patient's vasculature. The medical device may include one or more pressure wave emitters positioned along the central longitudinal axis of the elongated body. The one or more pressure wave emitters may be configured to propagate at least one pressure wave through the fluid to fragment the calcified lesion. At least one pressure wave emitter may include an optical fiber configured to transmit laser energy into the balloon. The laser energy may be configured to create a cavitation bubble in the fluid.

Systems for enabling delivery of very high peak power laser pulses through optical fibers for use in ablation procedures preferably in contact mode. Such lasers advantageously emit at 355 nm wavelength. Other systems enable selective removal of undesired tissue within a blood vessel, while minimizing the risk of damaging the blood vessel itself, based on the use of the ablative properties of short laser pulses of 320 to 400 nm laser wavelength, with selected parameters of the mechanical walls of the tubes constituting the catheter, of the laser fluence and of the force that is applied by the catheter on the tissues. Additionally, a novel method of calibrating such catheters is disclosed, which also enables real time monitoring of the ablation process. Additionally, novel methods of protecting the fibers exit facets are disclosed.

A method for treating a treatment site within or adjacent to a vessel wall or a heart valve, includes the steps of (i) generating light energy with a light source; (ii) positioning a balloon substantially adjacent to the treatment site, the balloon having a balloon wall that defines a balloon interior that receives a balloon fluid; (iii) receiving the light energy from the light source with a light guide at a guide proximal end; (iv) guiding the light energy with the light guide in a first direction from the guide proximal end toward a guide distal end that is positioned within the balloon interior; and (v) optically analyzing with an optical analyzer assembly light energy from the light guide, wherein the light energy that is analyzed moves in a second direction that is opposite the first direction.

An optical fiber assembly includes a central optical fiber core having a longitudinal axis surrounded by a cladding layer along the longitudinal axis, a distal end portion and a proximal end portion; it further comprises a layer of a material at least partially surrounding the cladding layer; the layer of material may be light-sensitive; and, at least two electrodes may be embedded at least partially along the longitudinal axis within the layer of light-sensitive material. The light-sensitive material may be a photoresist material, and the photoresist material characteristics change proportional to the amount of light impinging on the photoresist material. These characteristics may include one or more of electrical resistance changes or voltage changes.

A photocoagulation system is described herein that facilitates multi-spot laser treatment procedures inside the eye and close to the patient's retina. In one example embodiment, a modified endocular probe operates with a laser system to move the probe or a probe needle so as to project a multi-spot pattern on a patient's retina by controlling the rotation movement of the needle (and needle tip). In addition, the system facilitates maneuverability and angular deviation of the needle tip and synchronizes these different movements with the laser photocoagulator system so as to project the aiming beam and thereafter the laser treatment beam in the desired pattern location with the desired exposure time and power.

Apparatus and methods are described for laser ablation of tissue. The apparatus and methods utilize a laser source coupled to a fiberoptic laser delivery device and a laser driver and control system with features for protection of the laser delivery device, the patient, the operator and other components of the laser treatment system. Advantageously, the laser source may utilize laser diodes operating at approximately 975 nm, 1470 nm, 1535 nm or 1870 nm wavelengths with a laser power output of at least 60 watts, preferably greater than 80 watts and most preferably 120-150 watts or higher. The invention, which has broad medical and industrial applications, is described in relation to a method for treatment of benign prostatic hyperplasia (BPH) by contact laser ablation of the prostate (C-LAP).

Systems for enabling delivery of very high peak power laser pulses through optical fibers for use in ablation procedures preferably in contact mode. Such lasers advantageously emit at 355 nm wavelength. Other systems enable selective removal of undesired tissue within a blood vessel, while minimizing the risk of damaging the blood vessel itself, based on the use of the ablative properties of short laser pulses of 320 to 400 nm laser wavelength, with selected parameters of the mechanical walls of the tubes constituting the catheter, of the laser fluence and of the force that is applied by the catheter on the tissues. Additionally, a novel method of calibrating such catheters is disclosed, which also enables real time monitoring of the ablation process. Additionally, novel methods of protecting the fibers exit facets are disclosed.